Therapeuticsmd Inc (TXMD)

$2.31 +0.07 (3.12%)
Market Cap 25.93M
Revenue (ttm) 1.76M
Net Income (ttm) -2.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -123.86%
Debt to Equity Ratio 0.00
Volume 23,900
Avg Vol 72,960
Day's Range N/A - N/A
Shares Out 11.57M
Stochastic %K 80%
Beta 0.51
Analysts Strong Buy
Price Target $5.00

Company Profile

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 561 961 1900
Address:
951 Yamato Road, Suite 220, Boca Raton, United States
vijalp9
vijalp9 Mar. 20 at 4:18 PM
$TXMD Imvexxy 30% QoQ growth in Canada via Knight Tx licensing deal
0 · Reply
jfer333
jfer333 Mar. 19 at 3:11 AM
$TXMD oh man we’re fucking close.
2 · Reply
BillionerOfKing
BillionerOfKing Mar. 10 at 12:23 PM
$TXMD Current Stock Price: $2.30 Contracts to trade: $2.0 TXMD Mar 20 2026 Call Entry: $0.38 Exit: $0.56 ROI: 48% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
YPOJOB
YPOJOB Mar. 10 at 12:20 AM
$TXMD The judge said update your filings. Many more months. I hate the court system. Am I wrong?
1 · Reply
jfer333
jfer333 Mar. 9 at 2:10 PM
$TXMD who is ready for some fireworks !?🧨
2 · Reply
jfer333
jfer333 Mar. 6 at 3:08 PM
$TXMD docket movement finally. Judge is on it. Things are in motion
1 · Reply
Kobe2324
Kobe2324 Mar. 5 at 2:30 PM
$TXMD now I’m starting the clock, t-minus 5 days to higher volume.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 8:40 PM
$TXMD RSI: 21.87, MACD: 0.0075 Vol: 0.08, MA20: 2.30, MA50: 2.17 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Bio_Invest101
Bio_Invest101 Mar. 2 at 7:34 PM
$TXMD So many deals done in so many creative ways in the past 12 months. What exactly Rubric Capital Wants to accomplish? Soon it might run out of best time https://www.businesswire.com/news/home/20260301356096/en/Rallybio-Corporation-and-Candid-Therapeutics-Announce-Merger-Agreement
0 · Reply
YPOJOB
YPOJOB Feb. 26 at 10:22 PM
$TXMD Any news out there?
0 · Reply
Latest News on TXMD
TherapeuticsMD Announces Third Quarter 2025 Financial Results

Nov 12, 2025, 4:05 PM EST - 4 months ago

TherapeuticsMD Announces Third Quarter 2025 Financial Results

TherapeuticsMD Announces Second Quarter 2025 Financial Results

Aug 12, 2025, 4:05 PM EDT - 7 months ago

TherapeuticsMD Announces Second Quarter 2025 Financial Results

TherapeuticsMD Announces First Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 11 months ago

TherapeuticsMD Announces First Quarter 2025 Financial Results

TherapeuticsMD Announces Full Year 2024 Financial Results

Mar 27, 2025, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces Full Year 2024 Financial Results

TherapeuticsMD Announces Third Quarter 2024 Financial Results

Nov 12, 2024, 4:05 PM EST - 1 year ago

TherapeuticsMD Announces Third Quarter 2024 Financial Results

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

Aug 26, 2024, 7:36 AM EDT - 1 year ago

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

TherapeuticsMD Announces Second Quarter 2024 Financial Results

Aug 12, 2024, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces Second Quarter 2024 Financial Results

TherapeuticsMD Announces First Quarter 2024 Financial Results

May 10, 2024, 4:05 PM EDT - 2 years ago

TherapeuticsMD Announces First Quarter 2024 Financial Results

TherapeuticsMD Announces Full Year 2023 Financial Results

Mar 29, 2024, 4:00 PM EDT - 2 years ago

TherapeuticsMD Announces Full Year 2023 Financial Results

TherapeuticsMD Announces Third Quarter 2023 Financial Results

Nov 14, 2023, 4:05 PM EST - 2 years ago

TherapeuticsMD Announces Third Quarter 2023 Financial Results

TherapeuticsMD Announces Second Quarter 2023 Financial Results

Aug 14, 2023, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces Second Quarter 2023 Financial Results

TherapeuticsMD Announces First Quarter 2023 Financial Results

May 15, 2023, 4:05 PM EDT - 3 years ago

TherapeuticsMD Announces First Quarter 2023 Financial Results

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

Apr 7, 2023, 4:01 PM EDT - 3 years ago

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

Jan 3, 2023, 6:50 AM EST - 3 years ago

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

Dec 4, 2022, 6:00 PM EST - 3 years ago

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

TherapeuticsMD Announces Third Quarter 2022 Financial Results

Nov 14, 2022, 4:05 PM EST - 3 years ago

TherapeuticsMD Announces Third Quarter 2022 Financial Results

TherapeuticsMD Announces Additional $7 Million Private Placement

Oct 31, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Additional $7 Million Private Placement

TherapeuticsMD Announces $7 Million Private Placement

Oct 3, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces $7 Million Private Placement

TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

Sep 12, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

TherapeuticsMD Announces Second Quarter 2022 Financial Results

Aug 15, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Second Quarter 2022 Financial Results

TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022

Aug 8, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital

Aug 1, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital

Why TherapeuticsMD Shares Are Sinking Today?

Jul 13, 2022, 9:59 AM EDT - 4 years ago

Why TherapeuticsMD Shares Are Sinking Today?

TherapeuticsMD's stock falls 41% after tender offer expires

Jul 13, 2022, 8:25 AM EDT - 4 years ago

TherapeuticsMD's stock falls 41% after tender offer expires

TherapeuticsMD Announces Expiration of Tender Offer

Jul 13, 2022, 6:50 AM EDT - 4 years ago

TherapeuticsMD Announces Expiration of Tender Offer

EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer

Jul 6, 2022, 6:09 AM EDT - 4 years ago

EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer

5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More

Jun 21, 2022, 12:01 PM EDT - 4 years ago

5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More

WEBR

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

Jun 13, 2022, 10:49 AM EDT - 4 years ago

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

BEEM

EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD

Jun 6, 2022, 4:05 PM EDT - 4 years ago

EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD

THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD

May 31, 2022, 7:34 PM EDT - 4 years ago

THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD

Here is why TherapeuticsMD jumped 300%

May 31, 2022, 1:57 PM EDT - 4 years ago

Here is why TherapeuticsMD jumped 300%

Why TherapeuticsMD Stock Is Soaring Today

May 31, 2022, 10:12 AM EDT - 4 years ago

Why TherapeuticsMD Stock Is Soaring Today

TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD

May 31, 2022, 6:00 AM EDT - 4 years ago

TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD

Why TherapeuticsMD Shares Are Trading Higher Today

May 20, 2022, 10:54 AM EDT - 4 years ago

Why TherapeuticsMD Shares Are Trading Higher Today

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

May 20, 2022, 9:43 AM EDT - 4 years ago

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

TherapeuticsMD Announces First Quarter 2022 Financial Results

May 16, 2022, 4:05 PM EDT - 4 years ago

TherapeuticsMD Announces First Quarter 2022 Financial Results

TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022

May 10, 2022, 4:05 PM EDT - 4 years ago

TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

Apr 14, 2022, 4:15 PM EDT - 4 years ago

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

GDRX

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

Mar 10, 2022, 6:50 AM EST - 4 years ago

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

Why TherapeuticsMD Shares Are Soaring Today

Mar 7, 2022, 9:38 AM EST - 4 years ago

Why TherapeuticsMD Shares Are Soaring Today

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal

Mar 7, 2022, 7:57 AM EST - 4 years ago

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal

TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx

Mar 7, 2022, 7:40 AM EST - 4 years ago

TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx

GDRX

TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022

Mar 1, 2022, 4:30 PM EST - 4 years ago

TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022

FDA Approves TherapeuticsMD's Low Dose Bijuva

Jan 4, 2022, 6:20 AM EST - 4 years ago

FDA Approves TherapeuticsMD's Low Dose Bijuva

TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits

Dec 13, 2021, 6:08 AM EST - 4 years ago

TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits

U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA®

Dec 10, 2021, 4:30 PM EST - 4 years ago

U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA®

vijalp9
vijalp9 Mar. 20 at 4:18 PM
$TXMD Imvexxy 30% QoQ growth in Canada via Knight Tx licensing deal
0 · Reply
jfer333
jfer333 Mar. 19 at 3:11 AM
$TXMD oh man we’re fucking close.
2 · Reply
BillionerOfKing
BillionerOfKing Mar. 10 at 12:23 PM
$TXMD Current Stock Price: $2.30 Contracts to trade: $2.0 TXMD Mar 20 2026 Call Entry: $0.38 Exit: $0.56 ROI: 48% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
YPOJOB
YPOJOB Mar. 10 at 12:20 AM
$TXMD The judge said update your filings. Many more months. I hate the court system. Am I wrong?
1 · Reply
jfer333
jfer333 Mar. 9 at 2:10 PM
$TXMD who is ready for some fireworks !?🧨
2 · Reply
jfer333
jfer333 Mar. 6 at 3:08 PM
$TXMD docket movement finally. Judge is on it. Things are in motion
1 · Reply
Kobe2324
Kobe2324 Mar. 5 at 2:30 PM
$TXMD now I’m starting the clock, t-minus 5 days to higher volume.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 4 at 8:40 PM
$TXMD RSI: 21.87, MACD: 0.0075 Vol: 0.08, MA20: 2.30, MA50: 2.17 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Bio_Invest101
Bio_Invest101 Mar. 2 at 7:34 PM
$TXMD So many deals done in so many creative ways in the past 12 months. What exactly Rubric Capital Wants to accomplish? Soon it might run out of best time https://www.businesswire.com/news/home/20260301356096/en/Rallybio-Corporation-and-Candid-Therapeutics-Announce-Merger-Agreement
0 · Reply
YPOJOB
YPOJOB Feb. 26 at 10:22 PM
$TXMD Any news out there?
0 · Reply
Kobe2324
Kobe2324 Feb. 20 at 7:14 PM
$TXMD if history repeats itself I anticipate a spike in volume in the next 5-6 trading days
0 · Reply
YPOJOB
YPOJOB Feb. 20 at 1:59 AM
$TXMD Patience is ____________with this investment. Either we all are ________or _______. I trully think about this and change my answers to the blanks. Haha. Just trying to have fun today. I am still bullish but_______. I am still bearish but_______.
0 · Reply
hiTHit
hiTHit Feb. 17 at 4:14 PM
$TXMD I'm wearing headphones here; I don't want to listen to or interact with anyone. I will leave as soon as my shift here is over.🤓
0 · Reply
CapitalTrajectory
CapitalTrajectory Feb. 17 at 1:03 PM
$TXMD Women's health pharma; commercial challenges.
0 · Reply
trendricky
trendricky Feb. 17 at 8:27 AM
$TXMD Women's health pharma; commercial challenges
0 · Reply
NYCAristocrat
NYCAristocrat Feb. 13 at 6:13 PM
$TXMD 500 shares dropped this to 2.35 lol
0 · Reply
brenbto
brenbto Feb. 13 at 4:45 PM
$TXMD https://x.com/AnotherBio/status/2022338669345173883?s=20
0 · Reply
Kobe2324
Kobe2324 Feb. 12 at 1:10 PM
$TXMD what are the odds that news comes on earnings day vs random day?
2 · Reply
jfer333
jfer333 Feb. 11 at 2:10 AM
$TXMD For anyone wondering why Rubric became the parent… here’s the blueprint: 1️⃣ Buy broken asset cheap 2️⃣ Stabilize balance sheet 3️⃣ Clean up liabilities (lawsuit, legacy issues) 4️⃣ Add capacity (640M share authorization) 5️⃣ Roll in new assets / platform 6️⃣ Rebrand / restructure business model 7️⃣ Exit at scale 💰 This isn’t a side hustle. This is how PE/distressed funds build multi-baggers. We’re sitting between Steps 4 → 5 right now.
1 · Reply
NYCAristocrat
NYCAristocrat Feb. 9 at 5:52 PM
$TXMD we are close to a deal here. I think it wraps up end of 1Q, 2Q the latest
0 · Reply
ButterflyBets
ButterflyBets Feb. 9 at 3:10 PM
$TXMD Women's health pharmaceutical; has faced commercial execution challenges.
0 · Reply
Chazzzz1
Chazzzz1 Feb. 6 at 11:34 PM
$TXMD Big boys will play with this stock until they get what they want, which is a HUGE pop for TXMD. Just look at who is still involved with this nightmare.
0 · Reply